Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04923386Completed

mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels

Role: lead

NCT02779816Not ApplicableTerminated

Adaptive Device for Insulin Pens for Arthritic Patients

Role: lead

NCT02769585Not ApplicableCompleted

Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics

Role: lead

All 3 trials loaded